GLOBAL HEALTH ARCHITECTURE
Bali For The World in Health, Resilience and Happiness
TRI HITA KARANA ROAD TO G20 DIALOG | 27 August 2022
SPEAKERS
h.e. budi G. sadikin
Minister of Health, Republic of Indonesia
READ BIO
Born and raised in Bandung, West Java, Budi Gunadi Sadikin obtained his degree from Institute Technology of Bandung (ITB), majoring in Nuclear Physics. He took some prestigious insurance certification and banking programme abroad. Before being called for in government sector, he spent most of his career life as a banker which brought him to be the Director of Bank Mandiri in 2013. Before being appointed as the Minister of Health of Republic Indonesia in 2020, he was the Special Staff for the Minister of BUMN and the Vice Minister of BUMN.
H.E. SANDIAGA UNO
Minister of Tourism and Creative Economy, Republic of Indonesia
READ BIO
Sandiaga Uno is an Indonesian businessman, investor and politician who is the Minister of Tourism and Creative Economy, and was the Deputy Governor of Jakarta. Born in 1969, he graduated from Wichita State University in 1990 and from George Washington University with an MBA in 1992. He worked for several companies and rose in rank before founding his own business, which led him to become one of the richest people in Indonesia. In 2015, he resigned from his companies to join Gerindra. Upon his candidacy as vice president, he also renounced his membership in Prabowo’s Gerindra as part of the deal with coalition parties.
IR. W. BUDI SANTOSO, DIPL, HE
Deputy Chair III of KEK National Council
READ BIO
Susiwijono Moegiarso earned his bachelor degree in Managerial Economics at University of Indonesia and his master degree in Economics at University of Trisakti, Jakarta. Prior to becoming the Secretary of the Coordinating Ministry for Economic Affairs, he was a Special Staff to Ministry of Finance RI, Director at Admission and Regulation of Customs and Tax, Director General and Director Information of Customs and Tax at Ministry Finance RI.
ANDREW LO
Director of Financial Engineering at MIT Sloan School of Management
READ BIO
Andrew W. Lo is the Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management, director of the MIT Laboratory for Financial Engineering, a principal investigator at the MIT Computer Science and Artificial Intelligence Laboratory, and an affiliated faculty member of the MIT Department of Electrical Engineering and Computer Science. He is also an external faculty member of the Santa Fe Institute and a research associate of the National Bureau of Economic Research.
He has published numerous articles in finance and economics journals (see https://alomit.wpengine.com), and has authored several books including Adaptive Markets: Financial Evolution at the Speed of Thought, The Econometrics of Financial Markets, A Non-Random Walk Down Wall Street, Hedge Funds: An Analytic Perspective, and The Evolution of Technical Analysis. He is currently co-editor of the Annual Review of Financial Economics and advisor to the Journal of Investment Management and the Journal of Portfolio Management.
PHILIP YEO
Chairman of the Board of Directors of Economic Development Innovations Singapore
READ BIO
Philip Yeo graduated in Applied Science (Industrial Engineering) from University of Toronto under a Colombo Plan scholarship. He obtained his Master of Science in System Engineering from University of Singapore and MBA from Harvard University under a Fulbright scholarship. In addition, his contributions in Economic Development in Singapore and Asia has conferred him honorary PhDs from University of Toronto, Karolinska Institute in Sweden, National University of Singapore, Monash University, and Imperial College London.
He started serving in Singapore government sector in 1970. He served in various appointments in the Ministry of Defence, then became the chairman of Economic Development Board in 1986. He is a visionary person that was shown during his time in EDB when he redirected its focus from the traditional fields to new areas of business.
He is not only valuable in the government sector, but also in some private companies. He accepted many awards and some of them were granted because of his initiatives in enhancing or fostering good bilateral ties between Singapore and other countries. In his career in the Government of Singapore, developing people has been his passion that was shown by giving government funded scholarships to thousands of Singaporean.
Professor Sir Gordon Duff
Chairman of United In Diversity Foundation, Emeritus Prof. at St. Hilda College, Oxford University
READ BIO
Gordon studied Medicine at Oxford University and St Thomas’s Hospital, London, where he also gained a PhD in thermoregulation/fever. Following postgraduate medical training posts (including Royal Postgraduate Medical School, Hammersmith Hospital), he held junior faculty posts at Yale Medical School (Infectious Diseases and Pathology (Immunology) Depts), and the Howard Hughes Institute of Molecular Immunology at Yale. He joined Edinburgh Medical School in 1984, heading the Molecular Immunology Group, and in 1990 became the inaugural Florey Professor of Molecular Medicine at the University of Sheffield, where he was also Faculty Research Dean, Member of University Council, and Director of the Division of Genomic Medicine. With interests in inflammation, immunology, cytokines, therapeutics, biomedicines, public health and genetics, he has published ~ 400 research articles, and govt reports on medicines, vaccines and public health. He is co-inventor of ~35 biotech and diagnostic patents. (https://scholar. google. co. uk/citations? user=RPEVbnQAAAAJ&hl=en)
He was Knighted for services to the Public Health in 2007, and listed in the Science Council’s ‘Top 100′ working scientists in the UK’ in 2014. In 2016 he was awarded the Sir James Black Award from the British Pharmacological Society for the ‘Original Identification of TNF as a Therapeutic Target in Human Arthritis’. He is a Past-President of the International Cytokine Society and has received honorary doctorates from the Universities of Edinburgh and Sheffield. He was co- founding editor of the international research journal ‘CYTOKINE’, advisory editor to the Human Genome Organisation (HUGO) Journal. He has given the Croonian Lecture at the Royal College of Physicians of London, Weatherall Lecture at University of Oxford, Harry Bostrom Medal Lecture at Karolinska Institute, and Faculty Lecture at University of Geneva. He has lectured extensively at many international universities, professional societies and government agencies, including NIH (USA), FDA (USA), NCI (USA), Institut Pasteur (France), Biopolis (Singapore), Paul Ehrlich Institute (Germany), Sanger Centre Cambridge, Trinity College Dublin.
Advisory / Leadership: Gordon served on many SABs and funding panels in the UK, EU and US, including MRC, EPSRC Govt Foresight Groups, and Wellcome Trust. Previously Chair of the UK’s ‘Committee on Safety of Medicines’ (and of its Biologicals and Vaccines Sub-committee), he was inaugural Chair of the UK’s ‘Commission on Human Medicines’ (CHM, 2005-2012) before becoming Chair of the MHRA (national regulator of all UK medicines and medical devices). He was Chair of the Secretary-of-State’s ‘Expert Scientific Group on Phase One Clinical Trials’ following a clinical trial disaster in 2006 (TGN1412, the report made 22 recommendations to improve safety of first-in-human clinical trials). From 2002 to 2009 he was Chair of the UK’s ‘National Biological Standards Board’, overseeing the National Institute for Biological Standards and Control (NIBSC, WHO Centre), including setting up the National Stem Cell Bank, vCJD reagent repository and supplying ~95% of the world’s biological standards for diagnostics, biological medicines and vaccines. He was an advisor on Biological Medicines to the EU, and was Chair of the UK’s Scientific Pandemic Influenza Advisory Committee (SPI, 2006-10). In 2009-10, he co-chaired the UK Govt’s Scientific Advisory Group for Emergencies (SAGE) to tackle the H1N1 swine flu pandemic, accelerating procurement and distribution of antivirals, the approval of a specific vaccine and establishing a clinical data group. In 2010 he reviewed the UK’s Organ Donor Register, correcting coding errors. From 2015-2019 he was Chair of the UK’s Biotechnology and Biological Sciences Research Council (BBSRC), during the launch of the new Pirbright Institute for Animal Health. He chaired the Academic Health Science Centres of Imperial College London (2012-16), and Trinity College Dublin (2013-2020), and the MRC/NIHR National Phenome Centre at Imperial. He was Principal of St Hilda’s College, Oxford (2014-2021), a Pro-Vice Chancellor of the University of Oxford, Board member of OU’s Medical Sciences Division, and is an Honorary Fellow of both St Peter’s College and St Hilda’s College, Oxford. He is a Board member of the UK’s Foundation for Science and Technology, the Advisory Board of UPenn’s ‘Institute for Translational Medicine and Therapeutics’ (ITMAT), and UBC Vancouver’s Translational Medicine Board. He is currently President of the ‘United in Diversity Foundation’ (focused on implementing the UN’s Sustainable Development Goals), a Senior Research Fellow of NDORMS (Oxford Medical School), co-founder of Sitokine Ltd, and Chair of the International SAB of Silence Therapeutics.
tuti hadiputranto
President of Kura Kura Bali
READ BIO
Tuti Hadiputranto is a well-respected lawyer and one of the founding partners of Hadiputranto, Hadinoto, and Partners (HHP), or Baker MacKenzie Indonesia. Besides, she is the Chair of the Board of Directors of PT. Bentang Alam Indonesia, as well as the Chairman of the Capital Market Lawyers’ Professional Standards Board and Head of the Research and Development for the Capital Market Lawyers’ Association, where she is responsible for reviewing drafts of various securities regulations. Ms. Hadiputranto was the first lawyer to be registered with Bapepam to carry out capital market work in Indonesia. She has since been heavily involved in mergers and acquisitions and debt and corporate restructuring work for telecommunications and other major Indonesian companies.
TANTOWI YAHYA
Chairman of Kura Kura Bali
READ BIO
Tantowi Yahya was born in Palembang, South Sumatra. His career in the entertainment and hospitality industry from 1989. Being a country musician and TV host has given him a spot in the heart of Indonesian people. His passion in public speaking and politics has granted him both the opportunity and responsibility in diplomatic role as the Ambassador of New Zealand for Indonesia which was completed in the end of 2021. In 2022, he was appointed as the President United in Diversity (UID) to support its mission in building trust in continuous future and and the Chairman of Kura Kura Bali Turtle Island that offers support in various aspects towards Bali from the private sector.
DR. DRA. LUCIA RIZKA ANDALUCIA, APT., M. PHARM., MARS.,
Director General on Pharmacy and Medical Devices (Health Infrastructure)
READ BIO
Lucia Rizka Andalusia was born in Surabaya and was officially appointed as the Director General on Pharmacy and Medical Devices in 2021. Previously, she was the Director of Standardization of Medicine, Narcotics, Psychotropics, Precursor and Addictive Compound, also the Director of Registration of The Indonesian Food and Drug Authority. During the pandemic, she was assigned to be the spoken person of the COVID-19 vaccination for COVID-19 Response and National Economic Recovery Committee. She obtained her Doctoral Degree from University of Gajah Mada.
honesti basyir
CEO at PT. Bio Farma
READ BIO
Honesti Basyir is a technocrats, an econom, and a professional who currently is the CEO at PT. Bio Farma. Prior to his current position, he was the CEO at PT. Kimia Farma. Before pivoting his career to pharmaceutical industry, he was the CFO at PT. Telkom Indonesia for 23 years, Vice President Strategic Business Development IT Solution & Strategic Portfolio Department, also Assistant Vice President Business & Finance Analysis and Project Controller-1 Project Management Office. He is an Industrial Engineering graduate of Institute Technology of Bandung who continued his master education in Corporate Finance at the same university.
ELLIOTT SETIAWAN
Director of Investment, Indonesia Investment Authority (INA)
READ BIO
Elliott Setiawan graduated as a Bachelor of Commerce in Finance and Accounting at The University of British Columbia. He started his career as a senior associate at PricewaterhouseCoopers in 2006. Then he became an executive director at TC Capital. Afterwards, he spent more than 9 years at Affinity Equity Partners as the Vice President before joining Indonesia Investment Authority (INA).
maria palombini
Lead Healthcare Life Sciences Practice, IEEE Standards Association
READ BIO
Maria Palombini founded DisruptiveRx Media in 2016, which was the first information company to address the opportunities and challenges for the use of blockchain/DLTs in the pharmaceutical value chain. She currently leads the IEEE SA Healthcare Life Science Practice which is to mobilize a global community to evaluate and develop solutions to establish trust in disruptive technologies to protect, secure and offer a uniform quality of life for all.
She has enjoyed a significant and accomplished career in multiple industry sectors, both in the US and abroad. Her success has been the ability to motivate audiences to change a behavior and take an action. She currently holds an MBA from Rutgers School of Business and a B.A. and B.S. from Rutgers College at Rutgers University.
Ambassador curtis s. chin
Chairman, Asia, Milken Institute
READ BIO
Curtis S. Chin, a Milken Institute Asia fellow, has served as a trustee of World Education Services of New York and is a former U.S. ambassador to the Asian Development Bank. As a member of the ADB board, he pushed for strengthened governance, risk management and development efforts focused on people, planet, and partnership, particularly on infrastructure projects in Asia’s least-developed nations. Through his advisory firm RiverPeak Group LLC, Chin now advises a range of startup firms and impact investors in Asia, including Equator Pure Nature, a leading ASEAN-based, natural consumer products company and cleantech pioneer, and the Dolma Impact Fund, the first international equity fund focused on Nepal. Chin previously was a senior executive with Burson-Marsteller in the US, Switzerland, and Asia, where he oversaw Beijing and Hong Kong operations. He has provided counsel to a wide range of governments and businesses on stakeholder engagement, public affairs, corporate responsibility, crisis management and market entry.
DEDY PERMADI
Minister’s Special Advisor for Digital Policy and Human Resources Development and Spokesperson of the Ministry of Communications and Informatics, Republic of Indonesia
READ BIO
Dedy Permadi is an assistant Professor of International Relations in the Department of International Relations Universitas Gadjah Mada and currently aassisting the Minister of Communications and Informatics of the Republic of Indonesia in providing strategic and political analysis on subjects related to digital policy and human resources development. He is an advocate in promoting a holistic approach in digital policymaking with experiences in working with a diverse range of stakeholders, including the private sectors, scholars, and communities or civil societies. Previously, he worked as the Managing Director of Institute of International Studies and Director of Center for Digital Society Universitas Gadjah Mada. He is a graduate of Bachelor of Political Science and Master of Arts in International Relations at University of Gadjah Mada. In 2016, he earned his PhD in Public Policy at Lee Kuan Yew School of Public Policy.
SMAIL AIT ALI
Director Mass General Brigham Global Advisory
READ BIO
Smail Ait Ali is a Director at Mass General Brigham Global Advisory. He serves as primary leadership force and responsible for strategic planning, operations and overall partnership development for Advisory engagements and Global Alliance. In his role, he is responsible for defining, analyzing, building global partnerships. Smail has 17 years of experience in healthcare strategy, operations and business development with a focus on organization strategic alignments. Smail is a member of the American College of Healthcare Executives.
Prior to joining Mass General Brigham, Smail held numerous leadership positions in strategy, operations and business development at Mayo Clinic Rochester. He was the Operations Administrator responsible for leading and expanding the operating structure that consolidates external providers and patient strategy development and facilitates implementation of international affiliations and consulting engagements. Prior to that, he worked on numerous strategic initiatives in the office of access management, clinical practice and has advised clients as part of the American Healthcare Partners. He is fluent in Arabic, French and English. Smail earned a B.S. in Management Information Systems and holds a Masters in Project Management from St. Mary’s University in Minneapolis.
ANDREW WILTSHIRE
Head of Healthcare Public Policy at AWS
READ BIO
Andrew Wiltshire is a global experienced Senior Executive with a deep experience and expertise in healthcare business leadership and government relations, market access and external affairs. Expertise and leadership in the development and execution of reimbursement and market access strategies across product life cycles. Expert in Matrix collaboration locally and globally to collaborate, align and translation of global and local strategic direction to local strategic execution. He is a registered nurse who obtained his Bachelor of Arts in Humanities, Media Studies, and Media Production from Griffith University and MBA in Human Resources, Marketing from University of New England. He worked at Medtronic, a global healthcare company, for more than 20 years. His latest position there was Senior Director, Market Access, Public Affairs & Policy before joining some healthcare companies and organization and now he is the Head of Healthcare Public Policy (APAC) at Amazon Web Services in 2020.
AARON THAM
CEO of Kura Kura Bali
READ BIO
Aaron Tham was born in Singapore. He received his Bachelor of Chemical Engineering from University of Manchester – Institute of Science and Technology, then continued his postgraduate education at Imperial College London. As the CEO of Kura Kura Bali, he previously worked as the Director of New Estates Division at JTC Corporation and a Consultant for Ministry of Investment of Saudia Arabia. Besides, he was the Director of Singapore Economic Development for almost 17 years since 1996.
dr. somil nagpal
Senior Health Specialist, The World Bank
READ BIO
Dr. Somil Nagpal is Senior Health Specialist and cluster lead for the World Bank’s health and nutrition programs in Indonesia and Timor Leste and has been representing the World Bank team in the Joint Learning Network (JLN) for Universal Health Coverage since its inception. He graduated from Insurance Institution of India, earned his MBA at National Institute of Financial Management, MHA in Healthcare Management at Tata Institute of Social Sciences, and MBBS in Medicine/Surgery at MGM Medical College, Indore.